ArticleSensors (Basel, Switzerland)2025
Analysis of Voice, Speech, and Language Biomarkers of Parkinson's Disease Collected in a Mixed Reality Setting.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- GRU-Based Deep Multimodal Fusion of Speech and Head-IMU Signals in Mixed Reality for Parkinson's Disease Detection.Sensors (Basel, Switzerland) · 2026Article
- Speech Markers of Parkinson's Disease: Phonological Features and Acoustic Measures.Brain sciences · 2025Article
- The Effect of Data Leakage and Feature Selection on Machine Learning Performance for Early Parkinson's Disease Detection.Bioengineering (Basel, Switzerland) · 2025Article
- A Unified Deep Learning Ensemble Framework for Voice-Based Parkinson's Disease Detection and Motor Severity Prediction.Bioengineering (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study explores an innovative approach to early Parkinson's disease (PD) detection by analyzing speech data collected using a mixed reality (MR) system. A total of 57 Polish participants, including PD patients and healthy controls, performed five speech tasks while using an MR head-mounted display (HMD). Speech data were recorded and analyzed to extract acoustic and linguistic features, which were then evaluated using machine learning models, including logistic regression, support vector machines (SVMs), random forests, AdaBoost, and XGBoost. The XGBoost model achieved the best performance, with an F1-score of 0.90 ± 0.05 in the story-retelling task. Key features such as MFCCs (mel-frequency cepstral coefficients), spectral characteristics, RASTA-filtered auditory spectrum, and local shimmer were identified as significant in detecting PD-related speech alterations. Additionally, state-of-the-art deep learning models (wav2vec2, HuBERT, and WavLM) were fine-tuned for PD detection. HuBERT achieved the highest performance, with an F1-score of 0.94 ± 0.04 in the diadochokinetic task, demonstrating the potential of deep learning to capture complex speech patterns linked to neurodegenerative diseases. This study highlights the effectiveness of combining MR technology for speech data collection with advanced machine learning (ML) and deep learning (DL) techniques, offering a non-invasive and high-precision approach to PD diagnosis. The findings hold promise for broader clinical applications, advancing the diagnostic landscape for neurodegenerative disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.